Table 2
Invasive Cancer Incidence by Primary Site and Age at Diagnosis
Michigan Residents, 2014

Primary Site
  (ICD-O-3 Cancer Incidence
Site Groupings)
 
Total Less than 50 Years 50 - 74 Years 75 Years & Over
Number Age-
Adjusted
Rate
Number Age-
Specific
Rate
Number Age-
Specific
Rate
Number Age-
Specific
Rate
Gastrointestinal Tract
& Digestive System
10,556 86.9 ±1.6 984 15.7 ±1.0 6,396 215.1 ±5.1 3,176 483.3 ±15.8
Lip, Oral Cavity & Pharynx 1,455 11.9 ±0.6 169 2.7 ±0.4 1,001 33.7 ±2.1 285 43.4 ±5.0
Stomach 670 5.5 ±0.4 49 0.8 ±0.2 374 12.6 ±1.3 247 37.6 ±4.7
Colon 3,096 26.1 ±0.9 329 5.2 ±0.6 1,622 54.5 ±2.6 1,145 174.2 ±9.9
Rectum 1,512 12.6 ±0.6 218 3.5 ±0.5 954 32.1 ±2.0 340 51.7 ±5.5
Pancreas 1,539 12.4 ±0.6 78 1.2 ±0.3 940 31.6 ±2.0 521 79.3 ±6.7
Other Gastrointestinal
Tract & Digestive System
2,284 18.3 ±0.7 141 2.2 ±0.4 1,505 50.6 ±2.5 638 97.1 ±7.4
Respiratory System &
Pleura
8,357 67.7 ±1.4 316 5.0 ±0.6 5,401 181.6 ±4.7 2,640 401.7 ±14.6
Larynx 439 3.4 ±0.3 29 0.5 ±0.2 344 11.6 ±1.2 66 10.0 ±2.4
Lung & Bronchus 7,814 63.4 ±1.4 266 4.2 ±0.5 5,002 168.2 ±4.6  2,546 387.4 ±14.3
Other Respiratory 104 0.9 ±0.2 21 0.3 ±0.1 55 1.8 ±0.5 28 4.3 ±1.6
Bones & Soft Tissue 446 4.0 ±0.4 143 2.3 ±0.4 207 7.0 ±1.0 96 14.6 ±2.9
Melanoma of Skin 2,141 18.7 ±0.8 438 7.0 ±0.7 1,131 38.0 ±2.2 572 87.0 ±7.1
Breast 7,440 62.7 ±1.4 1,237 19.7 ±1.1  4,775 160.6 ±4.5 1,428 217.3 ±11.0
Genitourinary Organs 14,345 116.1 ±1.9 1,258 20.0 ±1.1 9,827 330.5 ±6.3 3,260 496.1 ±16.0
Cervix Uteri 311 3.1 ±0.4 158 2.5 ±0.4 129 4.3 ±0.7 24 3.7 ±1.5
Corpus Uteri  1,813 14.5 ±0.7 202 3.2 ±0.4 1,342 45.1 ±2.4 269 40.9 ±4.9
Ovary 694 6.0 ±0.4 120 1.9 ±0.3 402 13.5 ±1.3 172 26.2 ±3.9
Prostate Gland 6,080 46.7 ±1.2 146 2.3 ±0.4 4,875 163.9 ±4.5  1,059 161.2 ±9.5
Other Genital 673 6.4 ±0.5 282 4.5 ±0.5 272 9.1 ±1.1 119 18.1 ±3.2
Urinary Bladder  2,692 22.2 ±0.8 86 1.4 ±0.3 1,478 49.7 ±2.5 1,128 171.7 ±9.8
Kidney and Renal Pelvis  1,959 16.4 ±0.7 262 4.2 ±0.5  1,256 42.2 ±2.3 441 67.1 ±6.2
Other Urinary 123 1.0 ±0.2 2 *   73 2.5 ±0.6 48 7.3 ±2.1
Brain & Other Central
Nervous System
727 6.5 ±0.5 220 3.5 ±0.5 367 12.3 ±1.3 140 21.3 ±3.5
Lymphomas 2,561 22.0 ±0.8 472 7.5 ±0.7  1,345 45.2 ±2.4 744 113.2 ±8.0
Hodgkin Lymphoma 315 3.1 ±0.3 188 3.0 ±0.4 102 3.4 ±0.7 25 3.8 ±1.5
Non-Hodgkin Lymphoma 2,246 19.0 ±0.8 284 4.5 ±0.5  1,243 41.8 ±2.3 719 109.4 ±7.9
Multiple Myeloma 792 6.6 ±0.5 51 0.8 ±0.2 470 15.8 ±1.4 271 41.2 ±4.9
Leukemias 1,653 14.3 ±0.7 288 4.6 ±0.5 832 28.0 ±1.9 533 81.1 ±6.8
All Other 3,686 32.6 ±1.0 835 13.3 ±0.9 1,771 59.6 ±2.8 1,080 164.4 ±9.6
Total 52,704 438.2 ±3.6 6,242 99.3 ±2.4 32,522 1,093.7 ±10.4 13,940 2,121.3 ±26.8
               

Notes: Age-Specific Rates are per 100,000 population in a specific age group. Age-Adjusted Rates are per 100,000 population. Age-adjusted rates are computed by the direct method, using as the standard population the age distribution of the total population of the United States for the year 2000. Adding and subtracting the number shown after the ± symbol from the rate creates a confidence interval indicating that the true rate lies between the lower and upper bounds of this interval with 95 % statistical confidence.
Case : A case is defined as a person with any newly diagnosed cancer with a behavior code of 3 (malignant primary site). Both in-situ and invasive urinary bladder cancer cases are included, in order to be consistent with SEER tabulations from the National Cancer Institute.
* : A rate is not calculated when there are fewer than 20 total events, or fewer than 6 events in an age category, because the width of the confidence interval would negate any usefulness for comparative purposes.
Source: Michigan Resident Cancer Incidence File. Updated with cases processed through November 30, 2016. Division for Vital Records & Health Statistics, Michigan Department of Health & Human Services.
Last Updated: November 30, 2017